bcbs alabama glp 1 coverage GLP-1 for obesity treatment in 13 US states' Medicaid programs Delaware Weighs Cutting GLP-1 Coverage
Description
Beyond peptide agonists, non-peptide GLP-1R agonists like WB4-24 have also shown promise
After exhaustive review of the costs and consideration of long-term impacts and effectiveness of the drug, we believe that this is the right decision
Theres no pressure, no obligation just information and support from a team that cares
And GLP-1 drugs have other potential uses as treatment for Parkinson's disease, Alzheimer's disease, arthritis, and addiction, among other illnesses
Understanding how they fit into the broader landscape of weight loss compounds helps contextualize their relative strengths and weaknesses
